Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). It marks the latest device of this kind … [Read more...] about Prodeon gets FDA clearance for BPH-treating nitinol implant
